Articles from Oak HC/FT
Thesis Care (formerly Trovo Health), the AI-powered care team platform for scalable clinical capacity, announced $45 million in Series A funding led by Oak HC/FT, with participation from CRV, and additional support from Black Opal Ventures and experienced C-level healthcare technology angel investors. This brings the total funding for Thesis to $60 million.
By Oak HC/FT · Via Business Wire · March 25, 2026
Turquoise Health (“Turquoise”), a multi-sided healthcare pricing and payment platform, today announced it has raised $40 million in Series C funding. The round was led by Oak HC/FT, with participation from existing investors including Andreessen Horowitz, Adams Street Partners, and Yosemite.
By Oak HC/FT · Via Business Wire · March 17, 2026
Akido Labs, Inc. (“Akido”), the AI and care delivery company reimagining healthcare, today announced it has raised $60 million in Series B funding. The round was led by Oak HC/FT with participation from Greco, SNR, and existing investors Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Research), and the Comprehensive Blood & Cancer Center. Funding will be used to expand the reach of ScopeAI, a system that increases clinical capacity and improves healthcare access.
By Oak HC/FT · Via Business Wire · May 15, 2025
Toku, an account receivable SaaS platform, announced today that it has raised $48 million in Series A funding, bringing its total funding to $55 million. With this fundraise, Toku and CEO Cristina Etcheberry have raised the largest Series A by a female founder in Latin America. The round was led by Oak HC/FT, representing its fourth fintech investment in LatAm in the past three years. Existing investors, including Gradient Ventures (one of Google’s investment funds), F-Prime, Clocktower, Y Combinator, and Honey Island by 4UM, also participated.
By Oak HC/FT · Via Business Wire · April 17, 2025
Artis BioSolutions, a company founded to streamline the discovery, development and production of genetic medicines, today announced its launch, alongside its acquisition of Landmark Bio. Landmark Bio is a cell and gene therapy manufacturing company specializing in translational research, process development, and manufacturing technologies. As a part of Artis, Landmark Bio will continue to operate as a distinct entity, focused on accelerating therapeutic development from preclinical through commercialization.
By Oak HC/FT · Via Business Wire · April 2, 2025

Stepful, the company dedicated to re-imagining healthcare training for allied health professional jobs, today announced it has raised $31.5 million in Series B funding. The round was led by Oak HC/FT with participation from Y Combinator, Reach Capital, AlleyCorp, SemperVirens, Company Ventures, Green Sands, ECMC Education Impact Fund, Intermountain Ventures and Cedar Pine.
By Oak HC/FT · Via Business Wire · November 13, 2024

Cobre, a Colombia-based treasury platform that has been powering top Latin American CFO offices since 2020, announced today that it secured $35 million in Series B funding led by Oak HC/FT. Existing investors Kaszek, QED and Canary also participated in the round.
By Oak HC/FT · Via Business Wire · September 5, 2024

Trovo Health announced today that it is launching with a $15 million fundraise led by Oak HC/FT. Trovo uses an AI-powered platform backed by a multidisciplinary care team to help providers extend their capabilities. As part of the news, Andrew Adams, co-founder and managing partner at Oak HC/FT, will join the board of directors at Trovo Health.
By Oak HC/FT · Via Business Wire · April 30, 2024

Oak HC/FT, the premier venture growth-equity fund investing in Healthcare Information & Services and Financial Services Technology, today announced the appointment of Mike Matteo to Venture Partner with the Healthcare team. In this role, Mike will collaborate closely with the firm’s portfolio companies on a broad range of areas, including business strategy and commercialization.
By Oak HC/FT · Via Business Wire · August 24, 2021